BioPartners Overview

  • Year Founded
  • 2000

Year Founded

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • M&A

  • Financing Rounds
  • 2

  • Investments
  • 1

BioPartners General Information

Description

Owner and operator of a biotechnology company, primarily focusing on the development of drugs and bio-pharmaceuticals. The company's main products include: Valtropin, Interferon beta, Alpheon and Ravanex.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Formerly PE-Backed
Corporate Office
  • Sihlbruggstrasse 3
  • 6340 Baar
  • Switzerland
+41 041
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Acquirer
Vertical(s)
Corporate Office
  • Sihlbruggstrasse 3
  • 6340 Baar
  • Switzerland
+41 041

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

BioPartners Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore BioPartners‘s full profile, request access.

Request a free trial

BioPartners Patents

BioPartners Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20050123612-A1 Hepatitis c-virus (hcv); reduced waste Inactive 21-Dec-2001
ES-2238497-T3 Ribavirine granulate for the obtaining of filmed tablets. Inactive 21-Dec-2001
FR-2697645-B1 Method and device for reducing the water consumption of photographic film developing machines. Inactive 30-Oct-1992
FR-2697645-A1 Reduced water usage in photographic development - by addn. of biocide, dispersant and surfactant to washing tank and glycolic enzyme to overflow pipe Active 30-Oct-1992
FR-2622206-A1 Biological composition for cleaning discharges from equipment for developing photographic films and radiographic films Active 27-Oct-1987 G03C11/005
To view BioPartners’s complete patent history, request access »

BioPartners Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore BioPartners‘s full profile, request access.

Request a free trial

BioPartners Investments (1)

BioPartners’s most recent deal was a Early Stage VC with MagnaMedics. The deal was made on 01-Dec-2004.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
MagnaMedics 01-Dec-2004 Early Stage VC Biotechnology
To view BioPartners’s complete investments history, request access »

BioPartners Exits (1)

BioPartners’s most recent exit was on 01-Dec-2004 from MagnaMedics. The exit was categorized as with 3 buyers.

Company Name Exit Date Exit Type Exit Size Status Buyers
MagnaMedics 01-Dec-2004 Completed
  • 3 buyers
To view BioPartners’s complete exits history, request access »

BioPartners FAQs

  • When was BioPartners founded?

    BioPartners was founded in 2000.

  • Where is BioPartners headquartered?

    BioPartners is headquartered in Baar, Switzerland.

  • What industry is BioPartners in?

    BioPartners’s primary industry is Biotechnology.

  • Is BioPartners a private or public company?

    BioPartners is a Private company.

  • What is the current valuation of BioPartners?

    The current valuation of BioPartners is .

  • What is BioPartners’s current revenue?

    The current revenue for BioPartners is .

  • Who are BioPartners’s investors?

    Global Healthcare Partners and aPriori Capital Partners have invested in BioPartners.

  • When was BioPartners acquired?

    BioPartners was acquired on 09-Mar-2007.

  • Who acquired BioPartners?

    BioPartners was acquired by Bioton.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process